[1]苏殷婷,陈兆善,赖志昆.活血化瘀药在冠脉微血管功能障碍治疗中的运用规律[J].陕西中医,2023,(7):961-964.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.032]
　SU Yinting,CHEN Zhaoshan,LAI Zhikun.Application rules of Huoxue Huayu in coronary microvascular dysfunction[J].,2023,(7):961-964.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.032]
点击复制

活血化瘀药在冠脉微血管功能障碍治疗中的运用规律

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年7期
页码:
961-964
栏目:
方药纵横
出版日期:
2023-07-05

文章信息/Info

Title:
Application rules of Huoxue Huayu in coronary microvascular dysfunction
作者:
苏殷婷; 陈兆善; 赖志昆
(上海中医药大学附属市中医医院,上海 200071)
Author(s):
SU Yinting; CHEN Zhaoshan; LAI Zhikun
(Shanghai Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 200071,China)
关键词:
冠脉微血管功能障碍;  活血化瘀;  益气活血;  行气活血;  化痰祛瘀
Keywords:
Coronary microvascular dysfunction;  Huoxue Huayu;  Yiqi Huoxue;  Xingqi Huoxue;  Huatan Quyu
分类号:
R 543.3
DOI:
DOI:10.3969/j.issn.1000-7369.2023.07.032
文献标志码:
A
摘要:
冠脉微血管功能障碍的发病率逐年上升,已成为严重危害中老年患者的常见心血管疾病。现代医学在一定程度上能够改善冠脉微循环,增加冠脉灌注,减轻心肌缺血症状。由于冠脉微血管结构性、功能性障碍相互交错的复杂关系,治疗上缺乏有效的靶向药物。中医活血化瘀药治疗冠脉微血管功能障碍疗效较好,通过合理配伍和安全施用可充分发挥益气活血、行气活血、化痰祛瘀功效,发挥抑制血小板聚集、抗炎、缓解冠脉微血管痉挛、增加冠脉血流储备及改善心绞痛症状等作用。本研究着重对活血化瘀药治疗冠脉微血管功能障碍的临床应用及常用配伍、中西医结合治疗机制等进行探讨,为临床应用提供参考。
Abstract:
The incidence of coronary microvascular dysfunction(CMVD)is increasing year by year.CMVD is a common clinical cardiovascular disease,especially among middle-aged and elderly patients.Modern medicine can improve coronary microcirculation and increase coronary perfusion,in order to reduce myocardial ischemia.Due to complex relationship between structural and functional dysfunctions of coronary microvascular disease,effective targeted drugs are lacking.Huoxue Huayu have significant effect on CMVD and have certain characteristics in clinical application.Through reasonable compatibility and safe use,can fully play the role of Yiqi Huoxue,Xingqi Huoxue,Huatan Quyu to inhibit paltelet aggregation,anti-inflammatory,relieve coronary microvascular spasm,increase coronary flow reserve and improve anginal symptoms.Discuss clinical application,commonly used compatibility and mechanism of integrated Chinese and western medicine in the treatment of CMVD.

参考文献/References:

[1] Thakker RA,Rodriguez LJ,Rodriguez LP,et al.Coronary microvascular disease[J].Cardiol Ther,2022,11(1):23-31.
[2] Pries AR,Reglin B.Coronary microcirculatory pathophysiology:Can we afford it to remain a black box[J].Eur Heart Journal,2017,38(7):478-488.
[3] Spione F,Arevalos V,Gabani R,et al.Coronary microvascular angina:A state of the art review[J].Front Cardiovasc Med,2022,9(1):800-818.
[4] 贾红丹,国强华,毕希乐,等.替格瑞洛改善急性冠脉综合征患者冠脉微循环机制的研究进展[J].中国循证心血管医学杂志,2018,10(4):503-505.
[5] Yang Z,Lin S,Liu Y,et al.Traditional Chinese medicine in coronary microvascular disease[J].Front Pharmacol,2022,13(10):929-936.
[6] 陈 浩,龚 涛,王晓霞,等.中国多学科微血管疾病诊断与治疗专家共识[J].中国循环杂志,2020,35(12):1149-1165.
[7] 胡德胜,郭伟星,于 杰.心血管疾病活血化瘀论治[J].中西医结合心脑血管病杂志,2006,4(1):66-67.
[8] 陈 晨,刘 倩,高 华.活血化瘀药药理作用研究进展[J].中国药事,2011,25(6):603-605.
[9] 龚胜兰,范雅雯,牟 雷,等.中医药治疗冠脉微循环障碍用药规律的数据挖掘[J].中药新药与临床药理,2021,32(11):1731-1736.
[10] 张耀杰,朱海波,陈建军,等.基于网络药理学和分子对接探讨鸡血藤治疗冠脉微循环疾病机制[J].广西医科大学学报,2021,38(6):1107-1112.
[11] 刘 冬,高明堂,吴勇杰,等.丹参颗粒剂对实验性缺血心肌的保护作用和对凝血系统的影响[J].中药药理与临床,2008,24(1):43-47.
[12] 李 静,卢 峰,穆怀彬,等.基于MEK/ERK信号通路探究丹参酮ⅡA磺酸钠对缺氧复氧心脏微血管内皮细胞的保护作用[J].中国老年学杂志,2022,42(10):2452-2455.
[13] Fang J,Little PJ,Xu S.Atheroprotective effects and molecular targets of tanshinones derived from herbal medicine Danshen[J].Med Res Rev,2018,38(1):201-228.
[14] 王 静,董振华,芦 波,等.丹参活性成分及制剂在心血管病中的研究进展[J].时珍国医国药,2019,30(6):1453-1456.
[15] 周 鑫,孙晓莹,贾礼伊,等.中药单体川芎嗪在疾病治疗中的应用与机制研究进展[J].陕西中医,2022,43(4):541-544.
[16] Zhang Y,Ren P,Kang Q,et al.Effect of tetramethylpyrazine on atherosclerosis and SCAP/SREBP-1c signaling pathway in ApoE(-/-) mice fed with a high-fat diet[J].Evid Based Complement Alternat Med,2017,54(2):3121-3139.
[17] Liu X,Zhang M,Li Y,et al.Effects of levistilide a on hemorheology and endothelial cell injury in rats with blood stasis[J].Evid Based Complement Alternat Med,2021,57(5):6595-6603.
[18] 李 响,俱 蓉,李 硕.红花化学成分药理作用研究进展及质量标志物预测分析[J].中国现代中药,2021,23(5):928-939.
[19] 许香梅,王晓燕,刘曙光,等.红花黄色素注射液用于心绞痛治疗的临床效果及对患者心脏保护作用研究[J].中药材,2017,40(9):2209-2211.
[20] 马 军.三七总皂苷改善急性心肌梗死PCI术后心肌缺血再灌注损伤的临床研究[D].武汉:湖北中医药大学,2018.
[21] Meng Y,Du Z,Li Y,et al.The synergistic mechanism of total saponins and flavonoids in notoginseng-safflower pair against myocardial ischemia uncovered by an integrated metabolomics strategy[J].Biomed Pharmacother,2020,130(4):1105-1114.
[22] 白 鹭,李 鸿,覃 琴,等.黄酮类化合物对血管内皮细胞损伤的保护作用及机制研究进展[J].中国实验方剂学杂志,2020,26(12):203-211.
[23] 杨 靖,丛晓亮,吴宗贵.丹红注射液治疗冠状动脉微血管功能障碍的研究[J].湖北中医药大学学报,2015,17(1):34-36.
[24] 肖洪彬,赵艳明,王 海,等.桃仁、红花配伍对慢性血瘀模型大鼠血液流变学的影响[J].中医药信息,2005,22(4):75-76.
[25] 徐长福,沈盛晖,许 琳,等.血府逐瘀汤治疗原发性稳定型微血管心绞痛不同中医证型患者的疗效观察[J].心电与循环,2021,40(3):282-286.
[26] 田 露.黄芪丹参配伍改善微血管病变(虚瘀)与调节AQP1效应的研究[D].西安:第四军医大学,2017.
[27] 贡玉苗,司 靓,郭晓菊,等.麝香通心滴丸治疗微血管心绞痛的疗效及临床安全性研究[J].中国循证心血管医学杂志,2021,13(5):577-579.
[28] 乔 洵,陈晓虎,阮雪莲,等.从心络微型癥瘕理论探析冠状动脉微血管病变的病因病机[J].广西中医药,2020,43(6):33-35.
[29] 曲耿禄,吕腾腾,赵立群.基于玄府理论探讨辛味药在冠脉微血管疾病中的运用[J].中国中医急症,2022,31(8):1202-1205.
[30] 齐 锋,宋柏奇.基于痰瘀伏邪理论自拟莪术胶囊干预痰瘀互结型微血管性心绞痛临床观察[J].中西医结合心血管病电子杂志,2017,5(19):146-147.
[31] 张耀杰,莫霄云,杨 朔,等.基于网络药理学和动物实验探讨扶脉益心汤治疗冠脉微循环疾病的作用机制[J].广西医科大学学报,2021,38(7):1332-1338.

相似文献/References:

[1]曾薇薇,陆齐天,杨冰祎,等.基于“有故无殒,亦无殒也”探讨活血化瘀药物在妊娠病中的运用*[J].陕西中医,2020,(9):1289.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.032]
[2]王世卫,韩 佳,马民凯△,等.健脾补肾活血化瘀法治疗慢性肾功能衰竭疗效及对患者肾功能的影响*[J].陕西中医,2020,(11):1598.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.022]
[3]肖 岚,朱 宏,张 婷,等.董克礼教授治疗原发性肝癌临床经验*[J].陕西中医,2020,(11):1639.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.032]
　XIAO Lan,ZHU Hong,ZHANG Ting,et al.Experience of professor DONG Keli for treating primary liver cancer[J].,2020,(7):1639.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.032]
[4]林柏柏,沈梦雯,钱义明,等.从“痰饮”论治脓毒症毛细血管渗漏综合征[J].陕西中医,2021,(2):222.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.021]
　LIN Baibai,SHEN Mengwen,QIAN Yiming,et al.Treatment of sepsis capillary leakage syndrome from “phlegm and fluid”[J].,2021,(7):222.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.021]
[5]赵 亚,张勉之,樊威伟,等.国医大师张大宁治疗糖尿病肾病用药经验[J].陕西中医,2021,(6):773.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.025]
[6]冉瑞莹,尹 一,闫永彬.从瘀热互结论治儿童腺样体肥大[J].陕西中医,2021,(10):1436.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.029]
[7]凌丹凤,马丽然.补肾活血除湿法治疗早发性卵巢功能不全不孕症临床研究[J].陕西中医,2021,(12):1717.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.016]
　LING Danfeng,MA Liran.Clinical observation on the treatment of early-onset ovarian insufficiency infertility with Bushen Huoxue Chushi method[J].,2021,(7):1717.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.016]
[8]方泽彬,张曼怡,王高祥,等.李惠林论治肥胖型代谢综合征经验[J].陕西中医,2023,(3):367.[doi:DOI:10.3969/j.issn.1000-7369.2023.03.023]
[9]秦 天,吴文玉,蓝婉宁,等.基于“四位一体”理论分析桂枝茯苓丸治疗肺结节机制[J].陕西中医,2024,(4):520.[doi:DOI:10.3969/j.issn.1000-7369.2024.04.019]
[10]罗 丰,袁雪梅,王秋燚,等.基于气机升降理论辨治类风湿关节炎[J].陕西中医,2025,46(3):377.[doi:DOI:10.3969/j.issn.1000-7369.2025.03.019]
　LUO Feng,YUAN Xuemei,WANG Qiuyi,et al.Differentiation and treatment of rheumatoid arthritis based on theory of Qi movement[J].,2025,46(7):377.[doi:DOI:10.3969/j.issn.1000-7369.2025.03.019]

备注/Memo

备注/Memo:
基金项目:上海市卫生健康委员会临床医学专项课题(20204Y0260)
更新日期/Last Update: 2023-07-10